often
requir
comput
tomographi
ct
fiberopt
bronchoscopi
fob
bronchoalveolar
lavag
bal
fob
bal
gener
consid
safe
valuabl
procedur
evalu
pulmonari
complic
sct
recipi
undergo
infecti
pulmonari
workup
bal
specimen
evalu
array
diagnost
microbiolog
studi
target
variou
pathogen
includ
bacteria
mycobacteria
fungi
virus
prior
publish
studi
report
diagnost
yield
bal
rang
data
often
combin
diagnost
yield
infecti
noninfecti
pulmonari
complic
sct
recipi
report
focu
exclus
microbiolog
yield
bal
sct
recipi
therefor
sought
determin
elabor
overal
microbiolog
yield
bal
recipi
autolog
autosct
allogen
allosct
sct
underw
infecti
pulmonari
workup
institut
studi
cohort
consist
sct
recipi
underw
bal
procedur
januari
juli
institut
part
infecti
workup
fever
respiratori
symptom
new
pulmonari
radiograph
abnorm
patient
multipl
bronchoscopi
procedur
encount
consid
independ
procedur
patient
autosct
receiv
allosct
count
toward
allogen
dataset
ich
bal
order
set
institut
studi
period
con
follow
data
collect
bal
identifi
true
pathogen
respect
microorgan
isol
bal
sampl
autoand
allosct
recipi
list
tabl
true
pathogen
isol
bacteria
fungi
virus
mix
organ
bal
true
pathogen
identifi
patient
receiv
broadspectrum
antimicrobi
therapi
hour
bal
collect
empir
antimicrobi
therapi
prior
bal
administ
autosct
allosct
subgroup
respect
follow
pathogen
evalu
detail
pneumocysti
jirovecii
penicillium
speci
saccharomyc
speci
rhizopu
speci
coccidioid
speci
paecilomyc
speci
trichoderma
speci
bal
bronchoalveolar
lavag
autosct
autolog
stem
cell
transplant
allosct
allogen
stem
cell
transplant
esbl
extend
spectrum
pneumocysti
jirovecii
coccidioid
speci
virus
tabl
summar
clinic
inform
patient
pathogen
mrsa
isol
bal
cultur
fourteen
bal
cultur
reveal
collect
autoand
allosct
recipi
one
concur
legionella
isol
bal
retriev
autoand
allosct
concurr
posit
bal
legionella
pcr
two
case
diagnos
within
day
one
day
admiss
requir
intens
care
unit
admiss
day
later
twenti
bal
posit
aspergillu
autoand
allosct
patient
three
differ
method
use
assess
presenc
aspergillu
bal
cultur
bal
aspag
serum
aspag
eight
posit
result
detect
bal
p
jirovecii
detect
autoand
allosct
patient
case
bal
p
jirovecii
fluoresc
smear
test
test
posit
highdos
corticosteroid
therapi
given
case
case
receiv
p
jirovecii
prophylaxi
pentamidin
trimethoprimsulfamethoxazol
common
ct
find
among
case
diffus
ggo
coccidioid
speci
detect
bal
fungal
smear
cultur
pcr
posit
cocci
result
bal
pcr
concurr
posit
bal
cultur
neg
serum
cocci
serolog
posit
bal
cocci
pcr
allosct
patient
serum
cocci
serolog
test
case
posit
cocci
serolog
result
concord
bal
pcr
common
radiograph
find
chest
ct
consolid
ggo
common
virus
detect
ebv
follow
parainfluenza
viru
isol
autoand
allo
fifteen
bal
specimen
concurr
pathogen
common
combin
bacterium
fungu
follow
fungu
viru
bacteria
viru
bal
specimen
isol
pathogen
vulner
popul
fob
bal
consid
welltoler
safe
accur
procedur
complic
rate
fob
bal
sct
recipi
low
transbronchoscop
lung
biopsi
perform
addit
bal
complic
rate
high
safeti
profil
low
complic
rate
bal
make
commonli
use
diagnost
tool
sct
recipi
undergo
infecti
pulmonari
workup
administr
prophylact
preemptiv
antimicrobi
therapi
common
sct
patient
empir
antimicrobi
therapi
associ
improv
clinic
outcom
howev
earli
aggress
use
empir
regimen
conceptu
thought
decreas
microbiolog
yield
bal
sampl
cohort
patient
true
pathogen
identifi
bal
treatment
broadspectrum
antimicrobi
therapi
initi
least
hour
bal
collect
addit
cohort
bal
detect
mrsa
pseudomona
aspergillu
combin
take
appropri
therapi
target
specif
pathogen
therefor
receipt
concurr
antimicrobi
therapi
dissuad
oper
perform
bal
patient
popul
mrsa
pneumonia
associ
poor
outcom
frequent
necessit
empir
antibiot
therapi
recent
studi
report
neg
mrsa
pcr
ns
specimen
neg
predict
valu
mrsa
pneumonia
report
similar
find
wherein
mrsa
nss
perform
neg
bal
sputum
cultur
neg
case
neg
mrsa
seri
case
chest
ct
within
hour
fob
chest
ct
scan
may
sensit
chest
radiograph
ct
standard
diagnost
tool
initi
assess
invas
pulmonari
aspergillosi
opportunist
pulmonari
infect
sct
recipi
retrospect
studi
thu
inher
limit
assess
impact
bal
result
antimicrobi
therapi
ie
alter
initi
morbid
death
studi
design
analyz
microbiolog
yield
bal
specif
complic
rate
fob
collect
also
singleinstitut
studi
result
may
generaliz
sct
patient
institut
region
knowledg
largest
retrospect
studi
date
look
microbiolog
yield
fob
bal
sct
recipi
abl
demonstr
sputum
cultur
unreli
detect
pulmonari
pathogen
popul
addit
obtain
bal
sampl
despit
patient
receiv
antimicrobi
therapi
least
hour
sampl
collect
continu
valuabl
diagnost
test
consid
immunosuppress
cohort
bal
essenti
diagnost
tool
sct
recipi
undergo
infecti
pulmonari
workup
studi
show
overal
bal
microbiolog
yield
despit
group
receiv
empir
broadspectrum
antimicrobi
therapi
bal
collect
although
initi
bal
sampl
provid
critic
microbiolog
inform
repeat
bal
within
day
may
addit
diagnost
yield
kk
research
conceptdesign
data
collect
analysi
interpret
draft
articl
critic
revis
articl
approv
articl
ck
data
collect
analysi
critic
revis
articl
